Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease
Huoponen, Saara, Eberl, Anja, Räsänen, Pirjo, Roine, Risto P., Sipponen, Taina, Arkkila, Perttu, Blom, MarjaVolume:
99
Journal:
Medicine
DOI:
10.1097/MD.0000000000018723
Date:
January, 2020
File:
PDF, 390 KB
2020